| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Institute of Pathology,*
University of
Regensburg, Regensburg, and the Department of
Urology,
Ludwig Maximilian University,
Munich, Germany
In order to understand the origin of bladder cancer, very early urothelial lesions must be investigated in addition to more advanced tumors. Tissue from 31 biopsies of 12 patients with urothelial hyperplasias and simultaneous or consecutive superficial papillary tumors were used to microdissect urothelium from 15-µm sections of biopsies. The biopsies were obtained with the recently developed highly sensitive diagnostic method of 5-aminolevulinic acid-induced fluorescence endoscopy (AFE). Besides flat and papillary urothelial neoplasms, the method of photodynamic diagnostics also detects simple urothelial hyperplasias as fluorescent positive lesions. In addition, 12 fluorescence-positive biopsies showing histologically normal urothelium were investigated. Fluorescence in situ hybridization was done using a dual color staining technique of biotinylated centromeric probes of chromosomes 9 and 17 and digoxigenin-labeled gene-specific P1 probes for chromosomes 9q22 (FACC), 9p21(p16/CDKI2), and 17p13(p53). Ten of 14 hyperplasias (70%) showed deletions of chromosome 9. In 7 out of 8 patients with genetic alterations in the hyperplasias the genetic change was also present in the papillary tumor. Six out of 12 samples of microdissected normal urothelium also showed genetic alterations on chromosome 9. Microdissection of urothelial lesions, obtained during AFE, has led to the first unequivocal documentation of genetic changes in urothelial lesions diagnosed as normal in histopathology. Thus, this technical approach is important to provide insight into the earliest molecular alterations in bladder carcinogenesis.
This article has been cited by other articles:
 |
|
 |
|
  S Schwarz, M Rechenmacher, T Filbeck, R Knuechel, H Blaszyk, A Hartmann, and G Brockhoff Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions J. Clin. Pathol., March 1, 2008; 61(3): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Montironi, R Mazzucchelli, M Scarpelli, A Lopez-Beltran, and L Cheng Morphological diagnosis of urothelial neoplasms J. Clin. Pathol., January 1, 2008; 61(1): 3 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Jones, M. Wang, J. N. Eble, G. T. MacLennan, A. Lopez-Beltran, S. Zhang, A. Cocco, and L. Cheng Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis Clin. Cancer Res., September 15, 2005; 11(18): 6512 - 6519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Montironi and A. Lopez-Beltran The 2004 WHO Classification of Bladder Tumors: A Summary and Commentary International Journal of Surgical Pathology, April 1, 2005; 13(2): 143 - 153. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Wallerand, A. A. Bakkar, S. G. D. de Medina, J.-C. Pairon, Y.-C. Yang, D. Vordos, H. Bittard, S. Fauconnet, J.-C. Kouyoumdjian, M.-C. Jaurand, et al. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens Carcinogenesis, January 1, 2005; 26(1): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dyrskjot, M. Kruhoffer, T. Thykjaer, N. Marcussen, J. L. Jensen, K. Moller, and T. F. Orntoft Gene Expression in the Urinary Bladder: A Common Carcinoma in Situ Gene Expression Signature Exists Disregarding Histopathological Classification Cancer Res., June 1, 2004; 64(11): 4040 - 4048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Montironi, A Lopez-Beltran, R Mazzucchelli, and D G Bostwick Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies J. Clin. Pathol., February 1, 2003; 56(2): 91 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. N. Hopman, M. A. F. Kamps, E. J. M. Speel, R. F. M. Schapers, G. Sauter, and F. C. S. Ramaekers Identification of Chromosome 9 Alterations and p53 Accumulation in Isolated Carcinoma in Situ of the Urinary Bladder versus Carcinoma in Situ Associated with Carcinoma Am. J. Pathol., October 1, 2002; 161(4): 1119 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hartmann, G. Schlake, D. Zaak, E. Hungerhuber, A. Hofstetter, F. Hofstaedter, and R. Knuechel Occurrence of Chromosome 9 and p53 Alterations in Multifocal Dysplasia and Carcinoma in Situ of Human Urinary Bladder Cancer Res., February 1, 2002; 62(3): 809 - 818. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
